Synthesis and evaluation of 3-Phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors

被引:29
作者
Kumar, Anil
Wang, Yuehao
Lin, Xiaofeng
Sun, Gongqin
Parang, Keykavous
机构
[1] Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881
[2] Chemistry Group, Birla Institute of Technology and Science, Pilani, Rajasthan
[3] Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881
关键词
D O I
10.1002/cmdc.200700074
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
3 Phenylpyrozolo[3,4-d]pyrimidine (PhPP) derivatives substituted with an alkyl or aryl carboxylic acid at the N1-endocyclic amine, such as PhPP-CH2COOH (IC50=250 mu m), and peptides Ac-CIYKYY (IC50=400 mu m) and Ac-YIYGSFK (IC50=570 mu m) were weak inhibitors of polyE(4)Y phosphorylation by active c-Src. A series of PhPP-peptide conjugates were synthesized using PhPP as an ATP mimic and CIYKYY or YIYGSFK as a peptide substrate to improve the inhibitory potency against active c-Src kinose. PhPP derivatives were attached to the N terminus or the side chain of amino acids in the peptide template. Two N-terminal substituted conjugates, PhPP-CH2CO-CIYKYY (IC50=0.38 mu m) and PhPP-CH2CO-YIYGSFK (IC50 = 2.7 mu m), inhibited the polyE(4)Y phosphorylation by active c-Src significantly higher than that of the parent compounds. The conjugation of PhPP with the peptides produced a synergistic inhibition effect possibly through creation of favorable interactions between the conjugate and the kinase domain as shown by molecular modeling studies.
引用
收藏
页码:1346 / 1360
页数:15
相关论文
共 56 条
[1]
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase:: Conformational and topographical constraints in peptide design [J].
Alfaro-Lopez, J ;
Yuan, W ;
Phan, BC ;
Kamath, J ;
Lou, Q ;
Lam, KS ;
Hruby, VJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) :2252-2260
[2]
The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[3]
Biscardi JS, 1999, ADV CANCER RES, V76, P61
[4]
Design of allele-specific inhibitors to probe protein kinase signaling [J].
Bishop, AC ;
Shah, K ;
Liu, Y ;
Witucki, L ;
Kung, CY ;
Shokat, KM .
CURRENT BIOLOGY, 1998, 8 (05) :257-266
[5]
Selected glimpses into the activation and function of Src kinase [J].
Bjorge, JD ;
Jakymiw, A ;
Fujita, DJ .
ONCOGENE, 2000, 19 (49) :5620-5635
[6]
USE OF SYNTHETIC PEPTIDES AND COPOLYMERS TO STUDY THE SUBSTRATE-SPECIFICITY AND INHIBITION OF THE PROTEIN-TYROSINE KINASE PP60(C-SRC) [J].
BUDDE, RJA ;
OBEYESEKERE, NU ;
KE, S ;
MCMURRAY, JS .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1248 (01) :50-56
[7]
BUDDE RJA, 1994, CANCER BIOCHEM BIOPH, V14, P171
[8]
Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -: a selectivity insight [J].
Burchat, AF ;
Calderwood, DJ ;
Friedman, MM ;
Hirst, GC ;
Li, BQ ;
Rafferty, P ;
Ritter, K ;
Skinner, BS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) :1687-1690
[9]
Dorsey JF, 2000, CANCER RES, V60, P3127
[10]
Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability [J].
Eliceiri, BP ;
Paul, R ;
Schwartzberg, PL ;
Hood, JD ;
Leng, J ;
Cheresh, DA .
MOLECULAR CELL, 1999, 4 (06) :915-924